Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab and AVD in classical Hodgkin lymphoma
NCT03226249Phase 2Unknown
- Sponsor
- Northwestern University
- Start
- Nov 2017
- Primary completion
- May 2019
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in classical Hodgkin lymphoma (cHL), sponsored by Northwestern University. Status: unknown.
02
Drugs
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on NCT03226249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03226249.